Drug Pricing

End Of Session Hijinks Leave Consumers In Cold

As the legislature ended its business for the year in the early morning hours, legislative leaders proclaimed a prolific progressive session.  Not so if you care about consumer protection.
 
Key public interest causes were abandoned because of the power of the usual moneyed interest groups and the dependency of state house politicians on them.
 

Kaiser Family Foundation Gives Stage to Opponents of Prop 61's Drug Pricing Reform

What do supporters of drug price negotiation have to say when the pharmaceutical industry tries to shoot down drug pricing reforms?

You'd never know if you were watching Tuesday's webcast on prescription drugs and “Election-Cycle Proposals for Lowering Costs” hosted by the Kaiser Family Foundation (KFF) charity, which runs the nonprofit news service Kaiser Health News.

Can Drugmaking Goliath's $100 Million War Chest Stop David's Rx Relief Ballot Measure?

Big Pharma has put up $100 million to stop a ballot measure aimed at reining in California's prescription drug tab. Will $100 million be enough to stop a ballot measure that goes to the heart of the Bernie Sanders revolution?

Big Pharma Fattening Coffers to Stop Drug Price Reduction Initiative

Big Pharma fears only one thing: a government regulator who will push back on drug prices and protect consumers. Its fears could be realized in a year if an initiative intended to lower drug prices is approved by voters, which is why the drug companies have already filled a campaign war chest with nearly $40 million.
 

Capitol Watchdog is owned and operated by nonprofit Consumer Watchdog. For more information about Consumer Watchdog visit http://www.consumerwatchdog.org

 
 

Privacy Policy

  • Tel: 310-392-0522
  • Email: Contact [AT] CapitolWatchdog.org